Liqun Ren

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 6

Top Topics

Induced Apoptosis

Signaling Pathway

Ischemia Reperfusion Injury

Top Venues

BioMed research international

Journal of biochemical and molecular toxicology

Journal of cellular and molecular medicine

Molecular and cellular biochemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Qi Li, Zehui Gu, Qi Tan, Liqun Ren, Suxian Chen
MicroRNA-129-1-3p Represses the Progression of Triple-Negative Breast Cancer by Targeting the GRIN2D Gene. BioMed research international 2022 (2022)
Shuai Wang, Han Liu, Yang Zhang, Liqun Ren
Efficacy of Alkaloids in Alleviating Myocardial Ischemia-Reperfusion Injury in Rats: A Meta-Analysis of Animal Studies. BioMed research international 2021 (2021)
Qi Li, Dongsheng Xu, Zehui Gu, Tengteng Li, Peng Huang, Liqun Ren
Rutin restrains the growth and metastasis of mouse breast cancer cells by regulating the microRNA-129-1-3p-mediated calcium signaling pathway. Journal of biochemical and molecular toxicology 35 (7) (2021)
Qi Li, Meng Qin, Tengteng Li, Zehui Gu, Qi Tan, Peng Huang, Liqun Ren
Rutin protects against pirarubicin-induced cardiotoxicity by adjusting microRNA-125b-1-3p-mediated JunD signaling pathway. Molecular and cellular biochemistry 466 (1-2) (2020)
Qi Li, Meng Qin, Qi Tan, Tengteng Li, Zehui Gu, Peng Huang, Liqun Ren
MicroRNA-129-1-3p protects cardiomyocytes from pirarubicin-induced apoptosis by down-regulating the GRIN2D-mediated Ca2+ signalling pathway. Journal of cellular and molecular medicine 24 (3) (2020)
Meng Qin, Qi Li, Yadi Wang, Tengteng Li, Zehui Gu, Peng Huang, Liqun Ren
Rutin treats myocardial damage caused by pirarubicin via regulating miR-22-5p-regulated RAP1/ERK signaling pathway. Journal of biochemical and molecular toxicology 35 (1) (2020)